Maintenance therapy after stem-cell transplantation
Dr Laurent Garderet, MD from Saint-Antoine Hospital, Paris, France discusses autologous stem cell transplantation for patients with multiple myeloma (MM) at the European Society for Blood and Marrow Transplantation (EBMT) in Marseille, France. After transplantation, the response can reduce for some patients, therefore it is important to administer a maintenance treatment. Studies have demonstrated that maintenance therapy such as, lenalidomide, has a clear benefit to patients.
